| |
| |
|
| Insider
Information: |
Session R.a. Ii |
| Relationship: |
|
| City: |
Banockburn |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
8,881,747 |
|
|
Indirect Shares
|
282,180 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
9,163,927 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Avexis, Inc. |
AVXS |
Sr. VP, Corp Strategy |
2018-05-15 |
0 |
2018-03-13 |
0 |
Premium* |
|
|
Renovacor Ord Shs |
RCOR |
Director |
2020-04-23 |
10,000 |
|
0 |
Premium* |
|
|
Taysha Gene Therapies, Inc. |
TSHA |
|
2023-07-13 |
8,871,747 |
2023-07-13 |
282,180 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TSHA |
Taysha Gene Therapies, In... |
|
– – • |
2023-07-13 |
4 |
S |
$0.70 |
$3,741 |
D/D |
(5,344) |
8,871,747 |
0 |
- |
|
| TSHA |
Taysha Gene Therapies, In... |
|
– – • |
2023-07-12 |
4 |
S |
$0.71 |
$57,030 |
D/D |
(80,528) |
8,877,091 |
0 |
- |
|
| TSHA |
Taysha Gene Therapies, In... |
10% Owner |
– – • |
2023-06-23 |
4 |
S |
$0.70 |
$12,735 |
D/D |
(18,100) |
8,957,619 |
0 |
- |
|
| TSHA |
Taysha Gene Therapies, In... |
10% Owner |
– – • |
2023-06-22 |
4 |
S |
$0.70 |
$7,384 |
D/D |
(10,508) |
8,975,719 |
0 |
- |
|
| TSHA |
Taysha Gene Therapies, In... |
10% Owner |
– – • |
2023-06-21 |
4 |
S |
$0.70 |
$97,635 |
D/D |
(138,962) |
8,986,227 |
0 |
- |
|
| TSHA |
Taysha Gene Therapies, In... |
10% Owner |
– – • |
2023-06-20 |
4 |
S |
$0.71 |
$210,209 |
D/D |
(295,653) |
9,125,189 |
0 |
- |
|
| TSHA |
Taysha Gene Therapies, In... |
10% Owner |
– – • |
2023-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
251,296 |
9,420,842 |
0 |
- |
|
| TSHA |
Taysha Gene Therapies, In... |
President and CEO |
• • • |
2021-11-23 |
4 |
B |
$12.12 |
$529,102 |
D/D |
42,518 |
9,190,920 |
3.23 |
- |
|
| TSHA |
Taysha Gene Therapies, In... |
President and CEOOfficer |
• • • |
2020-09-23 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
282,180 |
|
- |
|
| TSHA |
Taysha Gene Therapies, In... |
President and CEOOfficer |
• • • |
2020-09-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,148,402 |
|
- |
|
| RCOR |
Renovacor Ord Shs |
Director |
– • – |
2020-04-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
10,000 |
|
- |
|
| AVXS |
Avexis, Inc. |
Sr. VP, Corp Strategy |
• – – |
2018-05-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,667) |
0 |
0 |
- |
|
| AVXS |
Avexis, Inc. |
Sr. VP, Corp Strategy |
• – – |
2018-03-13 |
4 |
A |
$0.00 |
$0 |
D/D |
1,667 |
1,667 |
0 |
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
